# Nabumetone

NDC: 50228-466
Generic name: Nabumetone
Labeler / Manufacturer: ScieGen Pharmaceuticals Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20190626

FDA application: ANDA078420

## Active ingredients

- NABUMETONE: 750 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50228-466"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50228-466
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=80c6888d-03b4-44f3-b94d-bcf5154ceae5